Skip to main content

Articles

Page 56 of 70

  1. An earlier study from our group of long time survivors of head and neck cancer who had received a low radiation dose to the hypothalamic-pituitary region, with no signs of recurrence or pituitary dysfunction, ...

    Authors: Erik Olsson, Carl Eckerström, Gertrud Berg, Magnus Borga, Sven Ekholm, Gudmundur Johannsson, Susanne Ribbelin, Göran Starck, Anna Wysocka, Elisabet Löfdahl and Helge Malmgren
    Citation: Radiation Oncology 2012 7:202
  2. To quantify the incidental irradiation dose to esophageal lymph node stations when irradiating T1-4N0M0 thoracic esophageal squamous cell carcinoma (ESCC) patients with a dose of 60 Gy/30f.

    Authors: Kai Ji, Lujun Zhao, Chengwen Yang, Maobin Meng and Ping Wang
    Citation: Radiation Oncology 2012 7:200
  3. We would like to investigate the if IMRT produced better target coverage and dose sparing to adjacent normal structures as compared with 3-dimensional conformal radiotherapy (3DCRT) and lateral opposing fields...

    Authors: Victor HF Lee, Sherry CY Ng, Cheuk Wai Choi, Mai Yee Luk, To Wai Leung, Gordon KH Au and Dora LW Kwong
    Citation: Radiation Oncology 2012 7:199
  4. Current clinical guidelines for the management of radiotherapy patients having either a pacemaker or implantable cardioverter defibrillator (both CIEDs: Cardiac Implantable Electronic Devices) do not cover mod...

    Authors: Coen W Hurkmans, Joost L Knegjens, Bing S Oei, Ad JJ Maas, GJ Uiterwaal, Arnoud J van der Borden, Marleen MJ Ploegmakers and Lieselot van Erven
    Citation: Radiation Oncology 2012 7:198
  5. To quantitatively evaluate the safety and related-toxicities of intensity modulated radiotherapy (IMRT) dose–volume histograms (DVHs), as compared to the conventional three-dimensional conformal radiotherapy (...

    Authors: Baojuan Yang, Lin Zhu, Haiyan Cheng, Qi Li, Yunyan Zhang and Yashuang Zhao
    Citation: Radiation Oncology 2012 7:197
  6. Low risk prostate cancers are commonly treated with low dose rate (LDR) brachytherapy involving I-125 seeds. The implementation of a ‘live-planning’ technique at the Royal Adelaide Hospital (RAH) in 2007 enabl...

    Authors: Joshua Moorrees, John M Lawson and Loredana G Marcu
    Citation: Radiation Oncology 2012 7:196
  7. Rectal cancer accounts for approximately one third of all colorectal cancers (CRC), which belong among leading causes of cancer deaths worldwide. Standard treatment for locally advanced rectal cancer (cT3/4 an...

    Authors: Marek Svoboda, Jiri Sana, Pavel Fabian, Ilona Kocakova, Jana Gombosova, Jana Nekvindova, Lenka Radova, Rostislav Vyzula and Ondrej Slaby
    Citation: Radiation Oncology 2012 7:195
  8. As the long-term efficacy of stereotactic body radiation therapy (SBRT) becomes established and other prostate cancer treatment approaches are refined and improved, examination of quality of life (QOL) followi...

    Authors: Alan Katz, Montserrat Ferrer and José Francisco Suárez
    Citation: Radiation Oncology 2012 7:194
  9. There is broad consensus on surgical resection being the backbone of curative therapy of gastric- and gastroesophageal junction carcinoma. Nevertheless, details on therapeutic approaches in addition to surgery...

    Authors: Daniel Buergy, Frank Lohr, Tobias Baack, Kerstin Siebenlist, Stefan Haneder, Henrik Michaely, Frederik Wenz and Judit Boda-Heggemann
    Citation: Radiation Oncology 2012 7:192
  10. Helical Tomotherapy (HT) has unique capacities for the radiotherapy of large and complicated target volumes. Next generation Dynamic Jaw/Dynamic Couch HT delivery promises faster treatments and reduced exposur...

    Authors: Sonja Krause, Sebastian Beck, Kai Schubert, Steffen Lissner, Susanta Hui, Klaus Herfarth, Juergen Debus and Florian Sterzing
    Citation: Radiation Oncology 2012 7:191
  11. Carbon fiber (CF) is now the material of choice for radiation therapy couch tops. Initial designs included side metal bars for rigidity; however, with the advent of IGRT, involving on board imaging, new thicke...

    Authors: Christopher F Njeh, Jason Parker, Joseph Spurgin and Elizabeth Rhoe
    Citation: Radiation Oncology 2012 7:190
  12. Limited data guide radiotherapy choices for patients with brain metastases. This survey aimed to identify patient, physician, and practice setting variables associated with reported preferences for different t...

    Authors: Marie-Adele S Kress, Naren Ramakrishna, Solomon B Makgoeng, Keith R Unger and Arnold L Potosky
    Citation: Radiation Oncology 2012 7:188
  13. Clinical studies have demonstrated that HPV induced tumors constitute a specific subclass of cancer with a better response to radiation treatment. The purpose of this study was to investigate meaning of viral ...

    Authors: Katja Lindel, Stefan Rieken, Sigrid Daffinger, Klaus J Weber, Ethel-Michele de Villiers and Jürgen Debus
    Citation: Radiation Oncology 2012 7:187
  14. Radiotherapy in Hodgkin’s Lymphoma (HL) is currently evolving with new attempts to further reduce radiation volumes to the involved-node concept (Involved Nodes Radiation Therapy, INRT) and with the use of int...

    Authors: Christian Fiandra, Andrea Riccardo Filippi, Paola Catuzzo, Angela Botticella, Patrizia Ciammella, Pierfrancesco Franco, Valeria Casanova Borca, Riccardo Ragona, Santi Tofani and Umberto Ricardi
    Citation: Radiation Oncology 2012 7:186
  15. To evaluate the value of dynamic contrast enhanced Magnetic Resonance Imaging (DCE-MRI) without endorectal coil (EC) in the detection of local recurrent prostate cancer (PC) after radical prostatectomy (RP).

    Authors: HansChristian Rischke, Arnd O Schäfer, Ursula Nestle, Natalja Volegova-Neher, Karl Henne, Matthias R Benz, Wolfgang Schultze-Seemann, Mathias Langer and Anca L Grosu
    Citation: Radiation Oncology 2012 7:185
  16. X-rays are known to interact with metallic nanoparticles, producing photoelectric species as radiosensitizing effects, and have been exploited in vivo mainly with gold nanoparticles. The purpose of this study was...

    Authors: Gi-Hwan Choi, Seung-Jun Seo, Ki-Hong Kim, Hong-Tae Kim, Sung-Hwan Park, Jae-Hong Lim and Jong-Ki Kim
    Citation: Radiation Oncology 2012 7:184
  17. Histone deacetylase (HDAC) plays an important role in the deacetylation of histone, which can alter gene expression patterns and affect cell behavior associated with malignant transformation. The aims of this ...

    Authors: Yang Han, Yong Zhang, Lian-he Yang, Xiao-yi Mi, Shun-dong Dai, Qing-chang Li, Hong-tao Xu, Juan-han Yu, Guang Li, Jing Zhao, Chong Han, Xi-ming Yuan and En-hua Wang
    Citation: Radiation Oncology 2012 7:183
  18. The purpose of this study is to investigate the prognostic factors of stereotactic radiotherapy for stage I NSCLC to improve outcomes.

    Authors: Yuko Shirata, Keiichi Jingu, Masashi Koto, Masaki Kubozono, Ken Takeda, Toshiyuki Sugawara, Noriyuki Kadoya and Haruo Matsushita
    Citation: Radiation Oncology 2012 7:182
  19. The presence of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) is associated with increased radiosensitivity in vitro. However, the results from clinical studies regarding...

    Authors: Hsin-Lun Lee, Tao-Sang Chung, Lai-Lei Ting, Jo-Ting Tsai, Shang-Wen Chen, Jeng-Fong Chiou, Henry Wing-Cheung Leung and H Eugene Liu
    Citation: Radiation Oncology 2012 7:181
  20. Gene silencing of O6-methylguanine–DNA methyltransferase (MGMT) by promoter methylation improves the outcome of glioblastoma patients after combined therapy of alkylating chemotherapeutic agents and radiation....

    Authors: Jens Jakob, Maren Hille, Christian Sauer, Philipp Ströbel, Frederik Wenz and Peter Hohenberger
    Citation: Radiation Oncology 2012 7:180
  21. Adult patients with hypothalamic-pituitary disorders have compromised quality of life (QoL). Whether this is due to their endocrine consequences (hypopituitarism), their underlying hypothalamic-pituitary disor...

    Authors: Elisabet Löfdahl, Gertrud Berg, Karl-Axel Johansson, Maria Leonsson Zachrisson, Helge Malmgren, Claes Mercke, Erik Olsson, Lena Wiren and Gudmundur Johannsson
    Citation: Radiation Oncology 2012 7:179
  22. Desmoid tumors are benign mesenchymal tumors with a strong tendency for local recurrence after surgery. Radiotherapy improves local control following incomplete resection, but nearby organs at risk may limit t...

    Authors: Whoon Jong Kil, R Charles Nichols Jr, John W Kilkenny, Soon Y Huh, Meng Wei Ho, Pratibha Gupta, Robert B Marcus and Daniel J Indelicato
    Citation: Radiation Oncology 2012 7:178
  23. The incidence of ductal carcinoma in situ (DCIS) has increased markedly in recent decades. In the past, mastectomy was the primary treatment for patients with DCIS, but as with invasive cancer, breast-conservi...

    Authors: Cristiana Vidali, Orazio Caffo, Cynthia Aristei, Filippo Bertoni, Alberto Bonetta, Marina Guenzi, Cinzia Iotti, Maria Cristina Leonardi, Salvatore Mussari, Stefano Neri and Nicoletta Pietta
    Citation: Radiation Oncology 2012 7:177
  24. To determine the outcome and patterns of failure in oral cavity cancer (OCC) patients after postoperative intensity modulated radiotherapy (IMRT) with concomitant systemic therapy.

    Authors: Andreas Geretschläger, Beat Bojaxhiu, Susanne Crowe, Andreas Arnold, Peter Manser, Wock Hallermann, Daniel M Aebersold and Pirus Ghadjar
    Citation: Radiation Oncology 2012 7:175
  25. Over the past 20 years, several proton beam treatment programs have been implemented throughout the United States. Increasingly, the number of new programs under development is growing. Proton beam therapy has...

    Authors: Robert L Foote, Scott L Stafford, Ivy A Petersen, Jose S Pulido, Michelle J Clarke, Steven E Schild, Yolanda I Garces, Kenneth R Olivier, Robert C Miller, Michael G Haddock, Elizabeth Yan, Nadia N Laack, Carola A S Arndt, Steven J Buskirk, Vickie L Miller, Christopher R Brent…
    Citation: Radiation Oncology 2012 7:174
  26. Proton-beam therapy (PBT) provides therapeutic advantages over conformal x-ray therapy in sparing organs at risk when treating esophageal cancer because of the fundamental physical dose distribution of the pro...

    Authors: Noriyuki Okonogi, Takatuki Hashimoto, Masaya Ishida, Toshiki Ohno, Toshiyuki Terunuma, Toshiyuki Okumura, Takeji Sakae and Hideyuki Sakurai
    Citation: Radiation Oncology 2012 7:173
  27. Erufosine is a promising anticancer drug that increases the efficacy of radiotherapy in glioblastoma cell lines in vitro. Moreover, treatment of nude mice with repeated intraperitoneal or subcutaneous injections ...

    Authors: Guido Henke, Verena Meier, Lars H Lindner, Hansjörg Eibl, Michael Bamberg, Claus Belka, Wilfried Budach and Verena Jendrossek
    Citation: Radiation Oncology 2012 7:172
  28. Merkel cell carcinoma (MCC) is a rare tumour of skin. This study is a retrospective audit of patients with MCC from St Vincent’s and Mater Hospital, Sydney, Australia. The aim of this study was to investigate ...

    Authors: Susan H Kang, Lauren E Haydu, Robin Yeong Hong Goh and Gerald B Fogarty
    Citation: Radiation Oncology 2012 7:171
  29. To report on establishment of workflow and clinical results of particle therapy at the Heidelberg Ion Therapy Center.

    Authors: Stephanie E Combs, Kerstin A Kessel, Klaus Herfarth, Alexandra Jensen, Susanne Oertel, Claudia Blattmann, Swantje Ecker, Angelika Hoess, Eike Martin, Olaf Witt, Oliver Jäkel, Andreas E Kulozik and Jürgen Debus
    Citation: Radiation Oncology 2012 7:170
  30. Adjuvant chemoradiotherapy is part of a multimodality treatment approach in order to improve survival outcomes after surgery for gastric cancer. The aims of this study are to describe the results of gastrectom...

    Authors: Wilson L Costa Jr, Felipe JF Coimbra, Ricardo C Fogaroli, Héber SC Ribeiro, Alessandro L Diniz, Maria Dirlei FL Begnami, Celso AL Mello, Marcelo F Fanelli, Milton JB Silva, José Humberto Fregnani and André L Montagnini
    Citation: Radiation Oncology 2012 7:169
  31. Radiation therapy (RT) is effective treatment for curing and palliating cancer, yet concern exists that not all Canadians for whom RT is indicated receive it. Many factors may contribute to suboptimal use of R...

    Authors: Caitlin Gillan, Kaleigh Briggs, Alejandro Goytisolo Pazos, Melanie Maurus, Nicole Harnett, Pamela Catton and David Wiljer
    Citation: Radiation Oncology 2012 7:167
  32. Robotic Stereotactic Body Radiation Therapy with real-time tumor tracking has shown encouraging results for hepatic tumors with good efficacy and low toxicity. We studied the factors associated with local cont...

    Authors: Sylvain Dewas, Jean-Emmanuel Bibault, Xavier Mirabel, Ingrid Fumagalli, Andrew Kramar, Hajer Jarraya, Thomas Lacornerie, Claire Dewas-Vautravers and Eric Lartigau
    Citation: Radiation Oncology 2012 7:166
  33. The histone deacetylase inhibitor vorinostat is a candidate radiosensitizer in locally advanced rectal cancer (LARC). Radiosensitivity is critically influenced by hypoxia; hence, it is important to evaluate th...

    Authors: Marie Grøn Saelen, Anne Hansen Ree, Alexandr Kristian, Karianne Giller Fleten, Torbjørn Furre, Helga Helseth Hektoen and Kjersti Flatmark
    Citation: Radiation Oncology 2012 7:165
  34. The purpose of this study is to evaluate the feasibility, efficacy and toxicity of SBRT for treatment of unresectable hepatic or lung metastases regardless of their primary tumor site for patients who received...

    Authors: Ingrid Fumagalli, Jean-Emmanuel Bibault, Sylvain Dewas, Andrew Kramar, Xavier Mirabel, Bernard Prevost, Thomas Lacornerie, Hajer Jerraya and Eric Lartigau
    Citation: Radiation Oncology 2012 7:164
  35. The purpose of this study was to compare the change in depth of target volume and dosimetric parameters between the supine and lateral decubitus positions for breast boost treatment with electron beam therapy.

    Authors: Neeta Kannan, Peyman Kabolizadeh, Hayeon Kim, Christopher Houser and Sushil Beriwal
    Citation: Radiation Oncology 2012 7:163
  36. Radiation therapy is an established modality in the treatment of head and neck cancer patients. Compromised wound healing in irradiated tissues is a common and challenging clinical problem. The pathophysiology...

    Authors: Frank Haubner, Elisabeth Ohmann, Fabian Pohl, Jürgen Strutz and Holger G Gassner
    Citation: Radiation Oncology 2012 7:162
  37. The management of resectable rectal cancer continues to be guided by clinical trials and advances in technique. Although surgical advances including total mesorectal excision continue to decrease rates of loca...

    Authors: William E Jones III, Charles R Thomas Jr, Joseph M Herman, May Abdel-Wahab, Nilofer Azad, William Blackstock, Prajnan Das, Karyn A Goodman, Theodore S Hong, Salma K Jabbour, Andre A Konski, Albert C Koong, Miguel Rodriguez-Bigas, William Small Jr, Jennifer Zook and W Warren Suh
    Citation: Radiation Oncology 2012 7:161
  38. To validate, in the context of adaptive radiotherapy, three commercial software solutions for atlas-based segmentation.

    Authors: Mariangela La Macchia, Francesco Fellin, Maurizio Amichetti, Marco Cianchetti, Stefano Gianolini, Vitali Paola, Antony J Lomax and Lamberto Widesott
    Citation: Radiation Oncology 2012 7:160
  39. The purpose of this study was to identify clinical and dosimetric factors associated with radiotherapy induced bone injury (RIBI) following stereotactic lung radiotherapy.

    Authors: Mojgan Taremi, Andrew Hope, Patricia Lindsay, Max Dahele, Sharon Fung, Thomas G Purdie, David Jaffray, Laura Dawson and Andrea Bezjak
    Citation: Radiation Oncology 2012 7:159
  40. To investigate whether patients treated for a localized prostate cancer (PCa) require a radical prostatectomy followed by postoperative radiotherapy or exclusive radiotherapy, in the modern era of image guided...

    Authors: Caroline Azelie, Mélanie Gauthier, Céline Mirjolet, Luc Cormier, Etienne Martin, Karine Peignaux-Casasnovas, Gilles Truc, Jérôme Chamois, Philippe Maingon and Gilles Créhange
    Citation: Radiation Oncology 2012 7:158
  41. Radiotherapy, preferably combined with chemotherapy, is the treatment standard for locally advanced, unresectable non-small cell lung cancer (NSCLC). The tumor response to different therapy protocols is variab...

    Authors: Vasileios Askoxylakis, Julien Dinkel, Monika Eichinger, Bram Stieltjes, Gregor Sommer, Ludwig G Strauss, Antonia Dimitrakopoulou-Strauss, Annette Kopp-Schneider, Uwe Haberkorn, Peter E Huber, Marc Bischof, Jürgen Debus and Christian Thieke
    Citation: Radiation Oncology 2012 7:157
  42. Unresectable pancreatic cancer (UPC) has low survival. With improving staging techniques and systemic therapy, local control in patients without metastatic disease may have increasing importance. We investigat...

    Authors: Daniel W Golden, Caroline J Novak, Bruce D Minsky and Stanley L Liauw
    Citation: Radiation Oncology 2012 7:156
  43. Independent external audits play an important role in quality assurance programme in radiation oncology. The audit supported by the IAEA in Serbia was designed to review the whole chain of activities in 3D con...

    Authors: Laza Rutonjski, Borislava Petrović, Milutin Baucal, Milan Teodorović, Ozren Čudić, Eduard Gershkevitsh and Joanna Izewska
    Citation: Radiation Oncology 2012 7:155
  44. Many prostate cancers demonstrate an increased expression of growth factor receptors such as vascular endothelial growth factor receptor (VEGFR) and platelet derived growth factor receptor (PDGFR) which have b...

    Authors: Colin Brooks, Tommy Sheu, Kathleen Bridges, Kathy Mason, Deborah Kuban, Paul Mathew and Raymond Meyn
    Citation: Radiation Oncology 2012 7:154
  45. Γ-Ionizing radiation (IR) therapy is one of major therapeutic tools in cancer treatment. Nevertheless, γ-IR therapy failed due to occurrence of metastasis, which constitutes a significant obstacle in cancer tr...

    Authors: Jong Kuk Park, Su Jin Jang, Sung Wook Kang, Sunhoo Park, Sang-Gu Hwang, Wun-Jae Kim, Joo Hyun Kang and Hong-Duck Um
    Citation: Radiation Oncology 2012 7:153
  46. Stereotactic ablative radiotherapy (SABR) can achieve excellent local control rates in early-stage non-small cell lung cancer (NSCLC) and has emerged as a standard treatment option for patients who cannot unde...

    Authors: Joe Y Chang, Hui Liu, Peter Balter, Ritsuko Komaki, Zhongxing Liao, James Welsh, Reza J Mehran, Jack A Roth and Stephen G Swisher
    Citation: Radiation Oncology 2012 7:152

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions